- Home
- KURA vs GFR Comparison
KURA vs GFR Comparison
Compare KURA & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- GFR
- Stock Information
- Founded
- KURA 2014
- GFR 2018
- Country
- KURA United States
- GFR Canada
- Employees
- KURA N/A
- GFR N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- GFR
- Sector
- KURA Health Care
- GFR
- Exchange
- KURA Nasdaq
- GFR Nasdaq
- Market Cap
- KURA 611.7M
- GFR 519.2M
- IPO Year
- KURA N/A
- GFR N/A
- Fundamental
- Price
- KURA $8.25
- GFR $6.38
- Analyst Decision
- KURA Strong Buy
- GFR Buy
- Analyst Count
- KURA 10
- GFR 1
- Target Price
- KURA $27.13
- GFR $10.50
- AVG Volume (30 Days)
- KURA 1.8M
- GFR 62.3K
- Earning Date
- KURA 02-26-2025
- GFR 03-04-2025
- Dividend Yield
- KURA N/A
- GFR N/A
- EPS Growth
- KURA N/A
- GFR N/A
- EPS
- KURA N/A
- GFR 0.40
- Revenue
- KURA N/A
- GFR $551,353,492.00
- Revenue This Year
- KURA N/A
- GFR $35.03
- Revenue Next Year
- KURA $280.91
- GFR $37.50
- P/E Ratio
- KURA N/A
- GFR $15.94
- Revenue Growth
- KURA N/A
- GFR 11.20
- 52 Week Low
- KURA $6.98
- GFR $4.68
- 52 Week High
- KURA $24.17
- GFR $8.16
- Technical
- Relative Strength Index (RSI)
- KURA 47.12
- GFR 37.04
- Support Level
- KURA $7.87
- GFR $6.40
- Resistance Level
- KURA $8.55
- GFR $6.67
- Average True Range (ATR)
- KURA 0.55
- GFR 0.19
- MACD
- KURA 0.03
- GFR 0.01
- Stochastic Oscillator
- KURA 43.48
- GFR 36.96
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.